Exagen Inc
NASDAQ:XGN
Exagen Inc
NASDAQ:XGN
Price:
1.98 USD
1.02%
Market Closed
Updated:
Jun 1, 2024
Exagen Inc
Other Liabilities
|
Exagen Inc
Other Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Exagen Inc
NASDAQ:XGN
|
Other Liabilities
$2.8m
|
CAGR 3-Years
36%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Liabilities
$32.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Liabilities
$3.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
24%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Liabilities
$6.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
0%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Liabilities
$1.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
51%
|
CAGR 10-Years
33%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Liabilities
$1.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
See Also
What is Exagen Inc's Other Liabilities?
Other Liabilities
2.8m
USD
2.8m
USD
Based on the financial report for Mar 31, 2024, Exagen Inc's Other Liabilities amounts to 2.8m USD.
What is Exagen Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-10%
-10%
Over the last year, the Other Liabilities growth was -44%. The average annual Other Liabilities growth rates for Exagen Inc have been 36% over the past three years , -10% over the past five years .
You don't have any saved screeners yet
